Mid-Atlantic Epilepsy and Sleep Center

Mid-Atlantic Epilepsy and Sleep Center (MAESC) is a premier medical practice and clinical research facility located in Bethesda, Maryland, specializing in the diagnosis and treatment of complex neurological and sleep disorders. Founded and directed by Dr. Pavel Klein, the center is a leading site for Phase 1 through Phase 4 clinical trials, collaborating with major pharmaceutical and biotechnology companies to evaluate novel therapeutics. MAESC provides comprehensive clinical services, including long-term video-EEG monitoring, sleep studies, and management of refractory epilepsy. The center is recognized for its high enrollment rates and significant contributions to the clinical development of several FDA-approved anti-seizure medications. By integrating cutting-edge research with patient care, MAESC offers patients access to emerging treatments for epilepsy, narcolepsy, and other central nervous system conditions.